111 related articles for article (PubMed ID: 15970536)
1. The herpes simplex virus type 2 protein ICP10PK: a master of versatility.
Smith CC
Front Biosci; 2005 Sep; 10():2820-31. PubMed ID: 15970536
[TBL] [Abstract][Full Text] [Related]
2. The herpes simplex virus type 2 gene ICP10PK protects from apoptosis caused by nerve growth factor deprivation through inhibition of caspase-3 activation and XIAP up-regulation.
Wales SQ; Li B; Laing JM; Aurelian L
J Neurochem; 2007 Oct; 103(1):365-79. PubMed ID: 17877640
[TBL] [Abstract][Full Text] [Related]
3. The herpes simplex virus type 2 R1 protein kinase (ICP10 PK) blocks apoptosis in hippocampal neurons, involving activation of the MEK/MAPK survival pathway.
Perkins D; Pereira EF; Gober M; Yarowsky PJ; Aurelian L
J Virol; 2002 Feb; 76(3):1435-49. PubMed ID: 11773417
[TBL] [Abstract][Full Text] [Related]
4. Ras-GAP binding and phosphorylation by herpes simplex virus type 2 RR1 PK (ICP10) and activation of the Ras/MEK/MAPK mitogenic pathway are required for timely onset of virus growth.
Smith CC; Nelson J; Aurelian L; Gober M; Goswami BB
J Virol; 2000 Nov; 74(22):10417-29. PubMed ID: 11044086
[TBL] [Abstract][Full Text] [Related]
5. The herpes simplex virus type 2 R1 protein kinase (ICP10 PK) functions as a dominant regulator of apoptosis in hippocampal neurons involving activation of the ERK survival pathway and upregulation of the antiapoptotic protein Bag-1.
Perkins D; Pereira EF; Aurelian L
J Virol; 2003 Jan; 77(2):1292-305. PubMed ID: 12502846
[TBL] [Abstract][Full Text] [Related]
6. Growth-compromised HSV-2 vector Delta RR protects from N-methyl-D-aspartate-induced neuronal degeneration through redundant activation of the MEK/ERK and PI3-K/Akt survival pathways, either one of which overrides apoptotic cascades.
Laing JM; Golembewski EK; Wales SQ; Liu J; Jafri MS; Yarowsky PJ; Aurelian L
J Neurosci Res; 2008 Feb; 86(2):378-91. PubMed ID: 17893911
[TBL] [Abstract][Full Text] [Related]
7. The PK domain of the large subunit of herpes simplex virus type 2 ribonucleotide reductase (ICP10) is required for immediate-early gene expression and virus growth.
Smith CC; Peng T; Kulka M; Aurelian L
J Virol; 1998 Nov; 72(11):9131-41. PubMed ID: 9765459
[TBL] [Abstract][Full Text] [Related]
8. The ribonucleotide reductase R1 subunits of herpes simplex virus types 1 and 2 protect cells against TNFα- and FasL-induced apoptosis by interacting with caspase-8.
Dufour F; Sasseville AM; Chabaud S; Massie B; Siegel RM; Langelier Y
Apoptosis; 2011 Mar; 16(3):256-71. PubMed ID: 21107701
[TBL] [Abstract][Full Text] [Related]
9. The transmembrane domain of the large subunit of HSV-2 ribonucleotide reductase (ICP10) is required for protein kinase activity and transformation-related signaling pathways that result in ras activation.
Smith CC; Luo JH; Hunter JC; Ordonez JV; Aurelian L
Virology; 1994 May; 200(2):598-612. PubMed ID: 8178446
[TBL] [Abstract][Full Text] [Related]
10. Vaccine potential of a herpes simplex virus type 2 mutant deleted in the PK domain of the large subunit of ribonucleotide reductase (ICP10).
Aurelian L; Kokuba H; Smith CC
Vaccine; 1999 Apr; 17(15-16):1951-63. PubMed ID: 10217594
[TBL] [Abstract][Full Text] [Related]
11. A mutant type 2 herpes simplex virus deleted for the protein kinase domain of the ICP10 gene is a potent oncolytic virus.
Fu X; Tao L; Cai R; Prigge J; Zhang X
Mol Ther; 2006 May; 13(5):882-90. PubMed ID: 16569513
[TBL] [Abstract][Full Text] [Related]
12. The protein kinase activity of the large subunit of herpes simplex virus type 2 ribonucleotide reductase (ICP10) fused to the extracellular domain of the epidermal growth factor receptor is ligand-inducible.
Smith CC; Luo JH; Aurelian L
Virology; 1996 Mar; 217(2):425-34. PubMed ID: 8610433
[TBL] [Abstract][Full Text] [Related]
13. The novel protein kinase of the RR1 subunit of herpes simplex virus has autophosphorylation and transphosphorylation activity that differs in its ATP requirements for HSV-1 and HSV-2.
Peng T; Hunter JR; Nelson JW
Virology; 1996 Feb; 216(1):184-96. PubMed ID: 8614985
[TBL] [Abstract][Full Text] [Related]
14. Multi-targeted neuroprotection by the HSV-2 gene ICP10PK includes robust bystander activity through PI3-K/Akt and/or MEK/ERK-dependent neuronal release of vascular endothelial growth factor and fractalkine.
Laing JM; Smith CC; Aurelian L
J Neurochem; 2010 Feb; 112(3):662-76. PubMed ID: 19891735
[TBL] [Abstract][Full Text] [Related]
15. Intracellular internalization and signaling pathways triggered by the large subunit of HSV-2 ribonucleotide reductase (ICP10).
Hunter JC; Smith CC; Bose D; Kulka M; Broderick R; Aurelian L
Virology; 1995 Jul; 210(2):345-60. PubMed ID: 7618272
[TBL] [Abstract][Full Text] [Related]
16. The R1 subunit of herpes simplex virus ribonucleotide reductase protects cells against apoptosis at, or upstream of, caspase-8 activation.
Langelier Y; Bergeron S; Chabaud S; Lippens J; Guilbault C; Sasseville AM; Denis S; Mosser DD; Massie B
J Gen Virol; 2002 Nov; 83(Pt 11):2779-2789. PubMed ID: 12388814
[TBL] [Abstract][Full Text] [Related]
17. The growth compromised HSV-2 mutant DeltaRR prevents kainic acid-induced apoptosis and loss of function in organotypic hippocampal cultures.
Gober MD; Laing JM; Thompson SM; Aurelian L
Brain Res; 2006 Nov; 1119(1):26-39. PubMed ID: 17020750
[TBL] [Abstract][Full Text] [Related]
18. The large subunit of herpes simplex virus type 2 ribonucleotide reductase (ICP10) is associated with the virion tegument and has PK activity.
Smith CC; Aurelian L
Virology; 1997 Aug; 234(2):235-42. PubMed ID: 9268154
[TBL] [Abstract][Full Text] [Related]
19. The ribonucleotide reductase domain of the R1 subunit of herpes simplex virus type 2 ribonucleotide reductase is essential for R1 antiapoptotic function.
Chabaud S; Sasseville AM; Elahi SM; Caron A; Dufour F; Massie B; Langelier Y
J Gen Virol; 2007 Feb; 88(Pt 2):384-394. PubMed ID: 17251554
[TBL] [Abstract][Full Text] [Related]
20. Herpes simplex virus type 2: unique biological properties include neoplastic potential mediated by the PK domain of the large subunit of ribonucleotide reductase.
Aurelian L
Front Biosci; 1998 Feb; 3():d237-49. PubMed ID: 9459654
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
